United States ex rel. Noah Nathan v. Takeda Pharmaceuticals, Inc. North America, Inc.
Petition for certiorari denied on March 31, 2014
Issue: Whether Rule 9(b) of the Federal Rules of Civil Procedure requires that a complaint under the
False Claims Act “allege with particularity that specific
false claims actually were presented to the government
for payment,” as required by the Fourth, Sixth, Eighth,
and Eleventh Circuits, or whether it is instead sufficient
to allege the “particular details of” the “scheme to submit
false claims” together with sufficient indicia that false
claims were submitted, as held by the First, Fifth, Seventh,
and Ninth Circuits.
Date | Proceedings and Orders (key to color coding) |
---|
Mar 29 2013 | Application (12A938) to extend the time to file a petition for a writ of certiorari from April 11, 2013 to May 10, 2013, submitted to The Chief Justice. |
Apr 4 2013 | Application (12A938) granted by The Chief Justice extending the time to file until May 10, 2013. |
May 10 2013 | Petition for a writ of certiorari filed. (Response due June 12, 2013) |
May 28 2013 | Order extending time to file response to petition to and including July 12, 2013. |
Jul 12 2013 | Brief of respondents Takeda Pharmaceuticals North America, Inc., et al. in opposition filed. |
Jul 30 2013 | Reply of petitioner U. S. ex rel. Noah Nathan filed. |
Jul 31 2013 | DISTRIBUTED for Conference of September 30, 2013. |
Oct 7 2013 | The Solicitor General is invited to file a brief in this case expressing the views of the United States. |
Feb 25 2014 | Brief amicus curiae of United States filed. |
Mar 12 2014 | DISTRIBUTED for Conference of March 28, 2014. |
Mar 12 2014 | Supplemental brief of petitioner U. S. ex rel. Noah Nathan filed. (Distributed) |
Mar 31 2014 | Petition DENIED. |